Search

DexCom Inc

Chiusa

SettoreSettore sanitario

78.54 0.94

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

76.41

Massimo

78.55

Metriche Chiave

By Trading Economics

Entrata

50M

249M

Vendite

117M

1.3B

P/E

Media del settore

34.119

49.241

EPS

0.7

Margine di Profitto

19.039

Dipendenti

11,000

EBITDA

52M

389M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+23.67% upside

Dividendi

By Acuity

Utili prossimi

29 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

4.1B

32B

Apertura precedente

77.6

Chiusura precedente

78.54

DexCom Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 ott 2026, 20:02 UTC

Dexcom Inc shares are declining, reversing a trend of higher daily closes observed since Wednesday's close.

21 ott 2026, 20:01 UTC

Dexcom Inc shares fell sharply, marking a downward shift and diverging from the recent trend of higher daily closes.

20 ott 2026, 20:08 UTC

Dexcom Inc shares are declining, pulling back from an earlier session high, and have dropped slightly since Monday's close.

19 ott 2026, 20:07 UTC

Dexcom Inc shares are declining, showing a slight drop since Friday's close amid routine market movement within the midpoint of its one-month trading range.

16 ott 2026, 23:06 UTC

Dexcom Inc shares are advancing modestly in after-market trading following Friday's close, currently positioned within the middle of its one-month trading range.

15 ott 2026, 20:02 UTC

Social Media
News

Dexcom Inc shares advanced sharply after the CONNECT study showed significant A1C reduction and improved glucose target range for users of the Dexcom G7.

14 ott 2026, 23:01 UTC

News

Dexcom's stock advanced in after-market trading following the CONNECT study publication, showing the G7 lowers A1C levels by an average of 1.6% for Type 2 diabetes patients.

13 ott 2026, 19:53 UTC

Dexcom Inc shares are declining amid significant downward movement in the Health Care Equipment sub-sector, currently positioned near the lower end of its one-month range.

12 ott 2026, 19:16 UTC

News

BTIG reiterates Buy rating on Dexcom Inc and raises price target to $96, according to a report released earlier today.

8 ott 2026, 19:15 UTC

Dexcom Inc shares are trading roughly flat, with a slight cumulative return since Wednesday's close, amid broader market weakness.

7 ott 2026, 23:55 UTC

Dexcom Inc's shares have declined in after-market trading, settling lower after an early high and remaining below their 20-day moving average.

6 ott 2026, 20:00 UTC

Dexcom Inc shares fell sharply, breaking a trend of higher daily closes established since Monday, amid a decline contrasting recent upward momentum.

5 ott 2026, 20:06 UTC

Dexcom Inc. is trading higher today, reflecting a generally positive market environment following an early dip and steady rise in broader market activity.

2 ott 2026, 20:07 UTC

Dexcom Inc's shares are declining, pulling back from earlier gains and trading below their 20-day moving average amid Friday's session.

30 set 2026, 20:07 UTC

Dexcom Inc shares fell lower Wednesday, following a modest decline from Tuesday's close, despite briefly peaking earlier in the session.

25 set 2026, 20:07 UTC

Dexcom Inc shares fell sharply, continuing a downward trajectory and closing lower compared to Thursday, remaining below its 20-day moving average.

23 set 2026, 20:07 UTC

Dexcom Inc shares fell sharply after an earlier rise, reflecting a decline compared to Tuesday's close amid broader market weakness.

22 set 2026, 20:07 UTC

Dexcom Inc is seeing a modest gain, reflecting stability near the upper end of its one-month range and above its 20-day moving average.

18 set 2026, 20:07 UTC

News

Dexcom Inc shares are advancing as Truist Securities raised its price target to $102 and TD Cowen reiterated its Buy rating with a $95 target.

17 set 2026, 19:26 UTC

News

Dexcom's stock is higher as Truist Securities raises its price target to $102.00 from $93.00, maintaining a Buy rating.

16 set 2026, 20:10 UTC

Dexcom Inc is trading higher, reaching a peak in late morning and settling above Tuesday's close, marking three consecutive daily gains.

15 set 2026, 20:01 UTC

Dexcom Inc shares are trading higher amid broader market concerns following a significant decline in the NY Empire State Manufacturing Index.

10 set 2026, 19:36 UTC

Dexcom Inc shares are higher in Thursday's session, recovering from an initial dip. The stock remains below its 20-day moving average. No specific news identified.

9 set 2026, 22:11 UTC

Dexcom Inc shares are higher in after-market trading, reflecting a positive shift since Wednesday's close, despite recent lower closes and no specific news.

8 set 2026, 20:01 UTC

Dexcom Inc. shares are lower today, trading significantly below their 20-day moving average amid speculation of a potential Federal Reserve interest rate hike.

28 ago 2026, 20:08 UTC

Dexcom Inc shares are higher today, aligning with a broader market increase. The asset is trading above its 20-day moving average.

26 ago 2026, 19:16 UTC

Dexcom Inc's shares are higher today, reaching their peak around 14:50 ET. The stock remains above its 20-day moving average.

25 ago 2026, 20:07 UTC

Dexcom Inc. shares are lower today amid broader market weakness. The stock remains above its 20-day moving average despite recent declines since Monday's close.

21 ago 2026, 19:36 UTC

Social Media

Dexcom Inc shares are higher as $1.6 million in call options signals bullish investor sentiment. The stock has recovered from earlier session lows.

20 ago 2026, 19:36 UTC

Dexcom Inc shares are higher today, continuing a three-session upward trend. The stock has fluctuated within a narrow range during regular trading hours.

Confronto tra pari

Modifica del prezzo

DexCom Inc Previsione

Obiettivo di Prezzo

By TipRanks

23.67% in crescita

Previsioni per 12 mesi

Media 96.389 USD  23.67%

Alto 115 USD

Basso 82 USD

Basato su 20 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per DexCom Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

20 ratings

19

Acquista

1

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
help-icon Live chat